Clinical Trial Update: The Efficacy of Coenzyme Q10 And Curcumin in Patients With Myelodysplastic Syndromes [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating Coenzyme Q10 and Curcumin in myelodysplastic syndromes has been withdrawn, covering Phase 1 and Phase 2 cohorts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Coenzyme Q10 (Coenzyme Q10)
• Curcumin (curcumin)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Myelodysplastic Syndrome | Phase 1, Phase 2 | Status: WITHDRAWN